{"nct_id":"NCT04035486","title":"A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2019-07-02","start_date_type":"ACTUAL","primary_completion_date":"2023-04-03","primary_completion_date_type":"ACTUAL","completion_date":"2026-06-03","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}